Description
An orally bioavailable inhibitor of Wnt signaling (IC50 = 5 nM); a potent and selective inhibitor of Cdk8 and Cdk19 that alters Wnt pathway-regulated gene expression,
Formal name: 8-[3-chloro-5-[4-(1-methyl-1H-pyrazol-4-yl)phenyl]-4-pyridinyl]-2,8-diazaspiro[4.5]decan-1-one
Synonyms:
Molecular weight: 421.9
CAS: 1661839-45-7
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|CDKs||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Cycle||Research Area|Cancer|Cell Signaling|Wnt Signaling||Research Area|Cell Biology|Cell Cycle||Research Area|Cell Biology|Cell Signaling|Wnt Signaling